Pediatric patients with leukemia have longer stay if admitted on weekend
the ONA take:
According to a new study published in The Journal of the American Medical Association Pediatrics, pediatric patients with newly diagnosed leukemia who were admitted to the hospital on the weekend had a longer length of stay, a small delay in initiating chemotherapy, and a greater risk for respiratory failure; however, these patients did not have an increased risk for death.
Researchers analyzed data from the Pediatric Health Information System database from 1999 to 2011 and identified 10,720 pediatric patients with newly diagnosed acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Of those, 16.7% were admitted to the hospital on the weekend. Patients admitted on the weekend had a 1.4-day longer length of stay, a 0.36-day longer time to chemotherapy initiation, and an increased risk for respiratory failure.
Researchers suggest that hospitals should consider the need to admit pediatric patients with leukemia and the clinical resources available on the weekend, and determine whether available resources are allocated to those patients who require comprehensive care. A longer length of stay and an increased risk for respiratory failure increase the cost of admission and may increase the risk for readmission.
Weekend admission for pediatric patients with leukemia associated with a longer length of stay.
Leukemia is a common childhood cancer that accounts for about 30 percent of all pediatric cancer diagnoses. Previous research has indicated an increased risk of death in adults with leukemia whose first admission was on a weekend. But there has been little investigation of weekend admissions for pediatric leukemia patients.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Apalutamide Prolongs Time to Metastasis in Castration-resistant Prostate Cancer
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|